Cargando…
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Life-threatening ‘breakthrough’ cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS-CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvacc...
Ejemplares similares
-
Evaluation of Clinical and Immunological Characteristics of Children with Common Variable Immunodeficiency
por: Alkan, Gülsüm, et al.
Publicado: (2018) -
Editorial: Macrophage activation syndrome in children in the era of COVID-19
por: Boyarchuk, Oksana, et al.
Publicado: (2023) -
The role of IL-12, IL-23 and IFN-γ in immunity to viruses
por: Novelli, Francesco, et al.
Publicado: (2004) -
Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED
por: Boyarchuk, Oksana, et al.
Publicado: (2023) -
Immunological mechanism of postherpetic neuralgia and effect of pregabalin treatment on the mechanism: a prospective single-arm observational study
por: Mercan, Aysel, et al.
Publicado: (2021)